Provided by Tiger Trade Technology Pte. Ltd.

3SBIO

15.540
-0.610-3.78%
Volume:35.81M
Turnover:559.08M
Market Cap:39.29B
PE:3.88
High:16.120
Open:16.120
Low:15.480
Close:16.150
52wk High:36.264
52wk Low:14.594
Shares:2.53B
HK Float Shares:2.53B
Volume Ratio:2.41
T/O Rate:1.42%
Dividend:0.26
Dividend Rate:1.69%
EPS(LYR):4.006
ROE:35.88%
ROA:22.68%
PB:1.22
PE(LYR):3.88
PS:1.88

Loading ...

Movement Alert|3SBio Rises 5.23% in Regular Trading, CMB International Recommends as Bottom Opportunity with Company Buyback Support

Market Focus
·
Jun 24

3SBIO Executes Share Buyback, Spending HK$15.7 Million on June 22

Stock News
·
Jun 22

3SBio Executes HKD 15.72 Million Share Buyback, Free-Float Down 0.04%

Bulletin Express
·
Jun 22

Movement Alert|3SBio Rises 5.04% in Regular Trading, Biotech Sector Collective Rebound Combined with Continuous Institutional Accumulation

Market Focus
·
Jun 18

Movement Alert|3SBio Falls 5.79% in Regular Trading, Biotech Sector Under Broad Pressure as Short-Selling Ratio Climbs

Market Focus
·
Jun 16

3SBIO Sees Major Share Purchase by Fullgoal Fund Management

Deep News
·
Jun 15

3SBIO Sees Major Share Purchase by Fund Manager at HK$16.28 Per Share

Stock News
·
Jun 12

Jing Lou Spends CN¥7.9m On 3SBio Stock

Simply Wall St.
·
Jun 11

3SBIO Shares Surge Over 6% in Afternoon Trading Following Chairman's Share Purchase Worth Approximately HK$7.87 Million

Deep News
·
Jun 10

Movement Alert|3SBio Rises 5.32% in Regular Trading, Chairman Stake Increase Combined with Medical Insurance Catalog Adjustment Boost Sentiment

Market Focus
·
Jun 10

3SBIO Chairman and CEO Lou Jing Acquires Additional 516,000 Shares at HK$15.2497 Each

Stock News
·
Jun 09

Innovative Drug Stocks Under Broad Selling Pressure as Liquidity Tightening Weighs on Valuations; Analysts View BINSA Bill Impact as Sentiment-Driven

Stock News
·
Jun 08

3SBIO Experiences Shareholding Reduction by China Universal Fund

Deep News
·
Jun 08

3SBIO Shares Reduced by Fund Manager, 2.16 Million Units Sold at Average Price of HK$17.15

Stock News
·
Jun 05

3SBio (01530) Calls 25 Jun 2026 AGM; Seeks 20% Share-Issue Mandate, 10% Buy-Back Power, HK$0.25 Final Dividend and Auditor Shift to KPMG

Bulletin Express
·
Jun 03

3SBio announces annual general meeting

Reuters
·
Jun 03

Stock Track | 3SBIO Plummets 7.40% Intraday as Biotech Sector Sees Profit-Taking After ASCO Catalyst Run-Up

Stock Track
·
Jun 02

Movement Alert|3SBio Falls 5.62% in Regular Trading, Biotech Sector Pulls Back After ASCO Catalyst

Market Focus
·
Jun 02

Stock Track | 3SBIO Soars 6.00% at Market Open on Positive ASCO Clinical Data and Pfizer Licensing Deal

Stock Track
·
Jun 01

Movement Alert|3SBio Rises 8% in Regular Trading, ASCO Annual Meeting SSGJ-707 Clinical Data Continues to Drive Momentum

Market Focus
·
Jun 01